Ruth Tal-Singer spent more than two decades at GlaxoSmithKline, where she was a top scientist studying COPD — a chronic lung disease often related to smoking. She’s published dozens of influential scientific papers. And she now helps run the nonprofit COPD Foundation.

So she was stunned when a recruiter contacted her this summer to see if she would be interested in working with Philip Morris International, the world’s largest listed tobacco company.